{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreib5ln4vz6iu3xa4mbvqheyk72vop2wijyv2ogjzschazk35us7qlu",
    "uri": "at://did:plc:2gbt2dlwaqovtnmxkat3tyke/app.bsky.feed.post/3mkrnm4begtx2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreieaourlpi5opkwqyqs2ftnvyynbvyobdef4rnge5uws2thmurmu3u"
    },
    "mimeType": "image/jpeg",
    "size": 288352
  },
  "path": "/articles/d41586-026-01353-7",
  "publishedAt": "2026-05-01T07:54:31.813Z",
  "site": "https://www.nature.com",
  "tags": [
    "doi:10.1038/d41586-026-01353-7"
  ],
  "textContent": "Nature, Published online: 30 April 2026; doi:10.1038/d41586-026-01353-7\n\nA biomarker shows which people with certain types of breast cancer are more likely to respond to an immune-based therapy.",
  "title": "Blood test hints at breast-tumour response to treatment",
  "updatedAt": "2026-04-30T00:00:00.000Z"
}